Vivos Inc (RDGL)

[AMB67]

Vet deals and the revenue that will follow will be very very significant and form the foundation of RDGL. Approval for humans may not occur in 2018. I sure hope it happens. Worst case scenario being next year around this time:

- ~90 Days (3 months) from January till completion of feline/canine sarcoma testing
- ~30 Days (1 month) prep time for Investigational Device Exemption (IDE) application submission
- ~30 Days (1 month) from reception of application for IDE approval
- ~30-60 Days (1-2 months) in human test prep time
- ~90 Days (3 months) to collect data
- ~30 Days (1 month) to prepare De Novo package
- within ~150 Days (5 months) from reception of application for possible De Novo approval

I am not concerned at all about human trials right now though. RDGL’s approach to penetrating the vet market is sound in my opinion. It will be more than enough to create long term value and hold shareholders over until FDA approval for the human side of things.